Ruiz-Mateos Ezequiel, de la Rosa Rafael, Soriano Natalia, Martinez-Moya Manuel, Rubio Amalia, Sánchez-Quijano Armando, Lissen Eduardo, Leal Manuel
Department of Internal Medicine, Virgen del Rocio University Hospital, Seville, Spain.
Antivir Ther. 2003 Aug;8(4):289-94.
The aim of this work was to compare thymic function-related markers for predicting early CD4 T-cell repopulation in adult HIV-infected patients under HAART. Forty-three consecutive antiretroviral-naive patients were prospectively analysed for clinical, biochemical, immunological and virological parameters at starting HAART, and followed for 4 weeks and every 12 weeks thereafter. At baseline, all patients underwent a thoracic computer tomography scan, in order to measure thymic volume, as well, T-cell phenotype (naive CD4 and CD8 T cells) and the number of TREC-bearing cells were obtained. CD4 cell repopulation was considered as an increase > or = 200 cells/mm3 above baseline count. Twenty-seven patients (62.8%) increased > or = 200 cells/mm3 above baseline levels during the follow-up. The median time to event was 182 days (84-537 days). On the univariate analysis, to be younger than 36 years, showing a CD4 cell count > or = 272 cells/mm3, a total naive T-cell count > or = 128 cells/mm3, a TREC-bearing cell count > or = 0.74 cells/mm3, and a thymic volume > or =3.07 cc at baseline were statistically associated to the event studied. However, when the multivariate analysis was performed, only thymic volume at baseline was independently associated (P=0.002) to CD4 cell recovery. This co-variable was identified as a positive predictor [hazard ratio, 1.22 (95% confidence interval: 1.16-1.28)]. In summary, data presented herewith show that thymic volume is the best thymic function-related marker for predicting early CD4 T-cell recovery in adult HIV-infected patients under HAART.
这项研究的目的是比较胸腺功能相关标志物,以预测接受高效抗逆转录病毒治疗(HAART)的成年HIV感染患者早期CD4 T细胞的重新增殖情况。对43例连续的初治抗逆转录病毒治疗患者在开始HAART时进行了临床、生化、免疫和病毒学参数的前瞻性分析,并在之后的4周以及此后每12周进行随访。在基线时,所有患者均接受胸部计算机断层扫描以测量胸腺体积,同时获取T细胞表型(初始CD4和CD8 T细胞)以及携带TREC的细胞数量。CD4细胞重新增殖被定义为高于基线计数增加≥200个细胞/mm³。27例患者(62.8%)在随访期间高于基线水平增加了≥200个细胞/mm³。事件发生的中位时间为182天(84 - 537天)。单因素分析显示,年龄小于36岁、CD4细胞计数≥272个细胞/mm³、总初始T细胞计数≥128个细胞/mm³、携带TREC的细胞计数≥0.74个细胞/mm³以及基线时胸腺体积≥3.07 cc与所研究的事件在统计学上相关。然而,在进行多因素分析时,只有基线时胸腺体积与CD4细胞恢复独立相关(P = 0.002)。该协变量被确定为阳性预测因子[风险比,1.22(95%置信区间:1.16 - 1.28)]。总之,此处呈现的数据表明,胸腺体积是预测接受HAART的成年HIV感染患者早期CD4 T细胞恢复的最佳胸腺功能相关标志物。